102 related articles for article (PubMed ID: 10352330)
1. Effect of granulocyte/colony-stimulating factor on the onset of the adult respiratory distress syndrome.
Takahashi Y; Kobayashi Y; Chikayama S; Ikeda M; Kondo M
Acta Haematol; 1999; 101(3):124-9. PubMed ID: 10352330
[TBL] [Abstract][Full Text] [Related]
2. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
3. Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome.
Matute-Bello G; Liles WC; Radella F; Steinberg KP; Ruzinski JT; Hudson LD; Martin TR
Crit Care Med; 2000 Jan; 28(1):1-7. PubMed ID: 10667491
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
Thomas X; Boiron JM; Huguet F; Reman O; Sutton L; Turlure P; Garban F; Gardin C; Espinouse D; Boulat O; Lhéritier V; Fiere D;
Hematol J; 2004; 5(5):384-94. PubMed ID: 15448664
[TBL] [Abstract][Full Text] [Related]
5. Alveolar granulocyte colony-stimulating factor and alpha-chemokines in relation to serum levels, pulmonary neutrophilia, and severity of lung injury in ARDS.
Wiedermann FJ; Mayr AJ; Kaneider NC; Fuchs D; Mutz NJ; Schobersberger W
Chest; 2004 Jan; 125(1):212-9. PubMed ID: 14718443
[TBL] [Abstract][Full Text] [Related]
6. Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
Woll PJ; Hodgetts J; Lomax L; Bildet F; Cour-Chabernaud V; Thatcher N
J Clin Oncol; 1995 Mar; 13(3):652-9. PubMed ID: 7533825
[TBL] [Abstract][Full Text] [Related]
7. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.
Estey E; Thall P; Andreeff M; Beran M; Kantarjian H; O'Brien S; Escudier S; Robertson LE; Koller C; Kornblau S
J Clin Oncol; 1994 Apr; 12(4):671-8. PubMed ID: 7512125
[TBL] [Abstract][Full Text] [Related]
8. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.
Sugawara Y; Fisher SJ; Zasadny KR; Kison PV; Baker LH; Wahl RL
J Clin Oncol; 1998 Jan; 16(1):173-80. PubMed ID: 9440740
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques.
Harousseau JL; Witz B; Lioure B; Hunault-Berger M; Desablens B; Delain M; Guilhot F; Le Prise PY; Abgrall JF; Deconinck E; Guyotat D; Vilque JP; Casassus P; Tournilhac O; Audhuy B; Solary E
J Clin Oncol; 2000 Feb; 18(4):780-7. PubMed ID: 10673519
[TBL] [Abstract][Full Text] [Related]
10. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
Crawford J; Ozer H; Stoller R; Johnson D; Lyman G; Tabbara I; Kris M; Grous J; Picozzi V; Rausch G
N Engl J Med; 1991 Jul; 325(3):164-70. PubMed ID: 1711156
[TBL] [Abstract][Full Text] [Related]
11. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study.
Ohno R; Miyawaki S; Hatake K; Kuriyama K; Saito K; Kanamaru A; Kobayashi T; Kodera Y; Nishikawa K; Matsuda S; Yamada O; Omoto E; Takeyama H; Tsukuda K; Asou N; Tanimoto M; Shiozaki H; Tomonaga M; Masaoka T; Miura Y; Takaku F; Ohashi Y; Motoyoshi K
J Clin Oncol; 1997 Aug; 15(8):2954-65. PubMed ID: 9256140
[TBL] [Abstract][Full Text] [Related]
12. Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensity.
Ribas A; Albanell J; Bellmunt J; Solé-Calvo LA; Bermejo B; Gallardo E; Vidal R; Vera R; Eres N; Carulla J; Baselga J
J Clin Oncol; 1996 May; 14(5):1573-80. PubMed ID: 8622074
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony-stimulating factor-producing lung cancer and acute respiratory distress syndrome.
Inokuchi R; Manabe H; Ohta F; Nakamura K; Nakajima S; Yahagi N
Clin Respir J; 2015 Apr; 9(2):250-2. PubMed ID: 24460739
[TBL] [Abstract][Full Text] [Related]
14. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
Rusthoven J; Bramwell V; Stephenson B
Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
[TBL] [Abstract][Full Text] [Related]
15. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor (G-CSF) treatment in a neutropenic leukemia patient with diffuse interstitial pulmonary infiltrates.
Heyll A; Aul C; Gogolin F; Thomas M; Arning M; Gehrt A; Hadding U
Ann Hematol; 1991 Dec; 63(6):328-32. PubMed ID: 1721841
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies.
Mignard X; Biard L; Lemiale V; Mokart D; Pène F; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Lebert C; Perez P; Meert AP; Benoit D; Hamidfar R; Darmon M; Azoulay E; Zafrani L
Leuk Lymphoma; 2019 May; 60(5):1156-1163. PubMed ID: 30277108
[TBL] [Abstract][Full Text] [Related]
18. Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
Bernstein SH; Fay JP; Christiansen NP; Pinero L; Shah D; Stephan M; Herzig GP
Clin Cancer Res; 1997 Sep; 3(9):1519-26. PubMed ID: 9815838
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.
Kushner BH; Heller G; Kramer K; Cheung NK
Cancer; 2000 Nov; 89(10):2122-30. PubMed ID: 11066054
[TBL] [Abstract][Full Text] [Related]
20. Risks of rhG-CSF treatment in drug-induced agranulocytosis.
Demuynck H; Zachée P; Verhoef GE; Schetz M; Van den Berghe G; Lauwers P; Boogaerts MA
Ann Hematol; 1995 Mar; 70(3):143-7. PubMed ID: 7536476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
